149 related articles for article (PubMed ID: 32274219)
21. Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression.
Wen L; Zou X; Chen Y; Bai X; Liang T
Front Immunol; 2020; 11():2076. PubMed ID: 32973816
[TBL] [Abstract][Full Text] [Related]
22. When Hormones are Being Difficult: A Rare Case and the Literature Review of Pembrolizumab-Induced Polyendocrinopathy.
Tayyeb M; Tariq M; Khan AM; Khalid F; Meghal T; Du D
J Community Hosp Intern Med Perspect; 2023; 13(6):90-94. PubMed ID: 38596553
[TBL] [Abstract][Full Text] [Related]
23. Diabetic ketoacidosis induced by a single dose of pembrolizumab.
Maamari J; Yeung SJ; Chaftari PS
Am J Emerg Med; 2019 Feb; 37(2):376.e1-376.e2. PubMed ID: 30361152
[TBL] [Abstract][Full Text] [Related]
24. Metformin in an HIV-infected patient with protease inhibitor-induced diabetic ketoacidosis.
Hughes CA; Taylor GD
Ann Pharmacother; 2001; 35(7-8):877-80. PubMed ID: 11485138
[TBL] [Abstract][Full Text] [Related]
25. Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma.
Kichloo A; Albosta MS; McMahon S; Movsesian K; Wani F; Jamal SM; Aljadah M; Singh J
J Investig Med High Impact Case Rep; 2020; 8():2324709620951339. PubMed ID: 32830561
[TBL] [Abstract][Full Text] [Related]
26. Programmed Cell Death-1 Inhibitor-Induced Type 1 Diabetes Mellitus.
Clotman K; Janssens K; Specenier P; Weets I; De Block CEM
J Clin Endocrinol Metab; 2018 Sep; 103(9):3144-3154. PubMed ID: 29955867
[TBL] [Abstract][Full Text] [Related]
27. Atezolizumab induced new-onset type 1 diabetes mellitus.
de Carlos J; Zabalza L; Garcia J; Marti M; Ayarza-Marien X; Yoldi J
J Oncol Pharm Pract; 2023 Jul; 29(5):1268-1270. PubMed ID: 36635950
[TBL] [Abstract][Full Text] [Related]
28. Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma.
Changizzadeh PN; Mukkamalla SKR; Armenio VA
J Immunother Cancer; 2017 Dec; 5(1):97. PubMed ID: 29254501
[TBL] [Abstract][Full Text] [Related]
29. Diabetic ketoacidosis induced by nivolumab in invasive mucinous adenocarcinoma of the lung: a case report and review of the literature.
Yan J; Xie ZZ; Moran T; Gridelli C; Zheng MD; Dai SJ
Ann Transl Med; 2022 Nov; 10(22):1256. PubMed ID: 36544678
[TBL] [Abstract][Full Text] [Related]
30. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
Zughaib MT; Patel K; Leka M; Affas S
Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune diabetes from pembrolizumab: A case report and review of literature.
Bhanderi H; Khalid F; Bodla ZH; Muhammad T; Du D; Meghal T
World J Clin Oncol; 2023 Nov; 14(11):535-543. PubMed ID: 38059185
[TBL] [Abstract][Full Text] [Related]
32. Type 1 diabetes mellitus induced by PD-1 inhibitors in China: a report of two cases.
Luo J; Feng J; Liu C; Yang Z; Zhan D; Wu Y; Pan L; Zhang L
J Int Med Res; 2022 Sep; 50(9):3000605221121940. PubMed ID: 36171723
[TBL] [Abstract][Full Text] [Related]
33. A case of pembrolizumab-induced fulminant Type 1 diabetes mellitus in breast cancer.
Tang Y; Zhao Z; Wang X; Zuo W; Zhang B; Yuan T; Fu Y
Immunotherapy; 2021 Apr; 13(6):483-489. PubMed ID: 33626915
[TBL] [Abstract][Full Text] [Related]
34. Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non-Small Cell Lung Cancer.
Leonardi GC; Oxnard GR; Haas A; Lang JP; Williams JS; Awad MM
J Immunother; 2017; 40(6):249-251. PubMed ID: 28557813
[TBL] [Abstract][Full Text] [Related]
35. Atezolizumab-Induced Autoimmune Diabetes in a Patient With Metastatic Lung Cancer.
Sothornwit J; Phunmanee A; Pongchaiyakul C
Front Endocrinol (Lausanne); 2019; 10():352. PubMed ID: 31244772
[No Abstract] [Full Text] [Related]
36. Fulminant diabetes due to immune checkpoint inhibitors in the emergency department.
Peyrony O; Ellouze S; Fontaine JP; Mohamadou I; Zafrani L
Am J Emerg Med; 2020 Feb; 38(2):408.e3-408.e4. PubMed ID: 31759780
[TBL] [Abstract][Full Text] [Related]
37. New-Onset Autoimmune Diabetes Mellitus Presenting As Diabetic Ketoacidosis in Association With Pembrolizumab Therapy and Long Term Follow-Up: Case Report.
Pachpande V; Mullangi S; Lekkala MR; Patel A
Cureus; 2022 Apr; 14(4):e24479. PubMed ID: 35651416
[TBL] [Abstract][Full Text] [Related]
38. Pheochromocytoma presenting with severe hyperglycemia and metabolic acidosis following intra-articular glucocorticoid administration: a case report.
Tomoyasu M; Mori Y; Fukase A; Kushima H; Hirano T
J Med Case Rep; 2019 Jan; 13(1):3. PubMed ID: 30609924
[TBL] [Abstract][Full Text] [Related]
39. New onset diabetes with ketoacidosis following nivolumab immunotherapy: A case report and review of literature.
Delasos L; Bazewicz C; Sliwinska A; Lia NL; Vredenburgh J
J Oncol Pharm Pract; 2021 Apr; 27(3):716-721. PubMed ID: 32723064
[TBL] [Abstract][Full Text] [Related]
40. Development of autoimmune diabetes with severe diabetic ketoacidosis and immune-related thyroiditis secondary to durvalumab: a case report.
Lopes AR; Russo A; Li AY; McCusker MG; Kroopnick JM; Scilla K; Mehra R; Rolfo C
Transl Lung Cancer Res; 2020 Oct; 9(5):2149-2156. PubMed ID: 33209634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
